Résumé :
|
[BDSP. Notice produite par INIST AF7zR0xn. Diffusion soumise à autorisation]. Context. - In British Columbia, human immunodeficiency virus (HIV) - infected persons eligible for antiretroviral therapy may receive it free but the extent to which HIV-infected injection drug users access it is unknown. Objective. - To identify patient and physician characteristics associated with antiretroviral therapy utilization in HIV-infected injection drug users. Design. - Prospective cohort study with record linkage between survey data and data from a provincial HIV/AIDS (acquired immunodeficiency syndrome) drug treatment program. Setting. - British Columbia, where antiretroviral therapies are offered free to all persons with HIV infection with CD4 cell counts less than 0.50x109/L (500/muL) and/or HIV-1 RNA levels higher than 5000 copies/mL. Subjects. - A total of 177 HIV-infected injection drug users eligible for antiretroviral therapy, recruited through the prospective cohort study since May 1996. Main Outcome Measures. - Patient use of antiretroviral drugs through the provincial drug treatment program and physician experience treating HIV infection. Results. - After a median of 11 months after first eligibility, only 71 (40%) of 177 patients had received any antiretroviral drugs, primarily double combinations (47/71 [66% ]). Both patient and physician characteristics were associated with use of antiretroviral drugs. (...)
|